Require Prescription
Description:
Benlysta (belimumab) is a medication used to treat systemic lupus erythematosus (SLE), a chronic autoimmune disease that can affect various parts of the body. It is administered intravenously and works by targeting specific components of the immune system involved in lupus.
Ingredients:
Active ingredient:
- Belimumab 120 mg per vial
Usage Instructions:
- Administered intravenously by a healthcare professional.
- Typically, the initial dose is given in two infusions, 2 weeks apart.
- Maintenance doses are then given once every 4 weeks.
- Dosage may vary based on individual patient factors and response to treatment.
Benefits:
- Reduces disease activity in systemic lupus erythematosus (SLE).
- Helps improve symptoms such as joint pain, fatigue, and skin rashes.
- Can decrease the need for other medications used to manage lupus.
Precautions:
- Not recommended for use in patients with severe active infections.
- Monitor patients for allergic reactions during infusion.
- May increase the risk of infections; precautions should be taken to avoid exposure to infections.
- Inform healthcare providers of all medications and conditions before starting treatment.
Storage Instructions:
- Store refrigerated between 2-8°C (36-46°F).
- Protect from light and do not freeze.
- Keep out of reach of children.
Manufacturer:
GlaxoSmithKline
